271 related articles for article (PubMed ID: 23279938)
1. Encapsulation of Acyclovir in new carboxylated cyclodextrin-based nanosponges improves the agent's antiviral efficacy.
Lembo D; Swaminathan S; Donalisio M; Civra A; Pastero L; Aquilano D; Vavia P; Trotta F; Cavalli R
Int J Pharm; 2013 Feb; 443(1-2):262-72. PubMed ID: 23279938
[TBL] [Abstract][Full Text] [Related]
2. Enhanced antiviral activity of Acyclovir loaded into beta-cyclodextrin-poly(4-acryloylmorpholine) conjugate nanoparticles.
Cavalli R; Donalisio M; Civra A; Ferruti P; Ranucci E; Trotta F; Lembo D
J Control Release; 2009 Jul; 137(2):116-22. PubMed ID: 19361545
[TBL] [Abstract][Full Text] [Related]
3. Enhanced antiviral activity of acyclovir loaded into nanoparticles.
Cavalli R; Donalisio M; Bisazza A; Civra A; Ranucci E; Ferruti P; Lembo D
Methods Enzymol; 2012; 509():1-19. PubMed ID: 22568898
[TBL] [Abstract][Full Text] [Related]
4. Preparation and in vitro evaluation of the antiviral activity of the Acyclovir complex of a beta-cyclodextrin/poly(amidoamine) copolymer.
Bencini M; Ranucci E; Ferruti P; Trotta F; Donalisio M; Cornaglia M; Lembo D; Cavalli R
J Control Release; 2008 Feb; 126(1):17-25. PubMed ID: 18079013
[TBL] [Abstract][Full Text] [Related]
5. Design, synthesis, and in vitro evaluation of new amphiphilic cyclodextrin-based nanoparticles for the incorporation and controlled release of acyclovir.
Perret F; Duffour M; Chevalier Y; Parrot-Lopez H
Eur J Pharm Biopharm; 2013 Jan; 83(1):25-32. PubMed ID: 23072941
[TBL] [Abstract][Full Text] [Related]
6. Novel nanoparticles made from amphiphilic perfluoroalkyl alpha-cyclodextrin derivatives: preparation, characterization and application to the transport of acyclovir.
Ghera BB; Perret F; Chevalier Y; Parrot-Lopez H
Int J Pharm; 2009 Jun; 375(1-2):155-62. PubMed ID: 19481701
[TBL] [Abstract][Full Text] [Related]
7. Nanosponge formulations as oxygen delivery systems.
Cavalli R; Akhter AK; Bisazza A; Giustetto P; Trotta F; Vavia P
Int J Pharm; 2010 Dec; 402(1-2):254-7. PubMed ID: 20888402
[TBL] [Abstract][Full Text] [Related]
8. Controlled drug release system based on cyclodextrin-conjugated poly(lactic acid)-b-poly(ethylene glycol) micelles.
He Q; Wu W; Xiu K; Zhang Q; Xu F; Li J
Int J Pharm; 2013 Feb; 443(1-2):110-9. PubMed ID: 23328682
[TBL] [Abstract][Full Text] [Related]
9. Galactose decorated PLGA nanoparticles for hepatic delivery of acyclovir.
Gupta S; Agarwal A; Gupta NK; Saraogi G; Agrawal H; Agrawal GP
Drug Dev Ind Pharm; 2013 Dec; 39(12):1866-73. PubMed ID: 22397550
[TBL] [Abstract][Full Text] [Related]
10. Chitosan/sulfobutylether-β-cyclodextrin nanoparticles as a potential approach for ocular drug delivery.
Mahmoud AA; El-Feky GS; Kamel R; Awad GE
Int J Pharm; 2011 Jul; 413(1-2):229-36. PubMed ID: 21540097
[TBL] [Abstract][Full Text] [Related]
11. Controlled release polymeric ocular delivery of acyclovir.
Deshpande PB; Dandagi P; Udupa N; Gopal SV; Jain SS; Vasanth SG
Pharm Dev Technol; 2010; 15(4):369-78. PubMed ID: 19772377
[TBL] [Abstract][Full Text] [Related]
12. Development of solid lipid nanoparticles and nanostructured lipid carriers for improving ocular delivery of acyclovir.
Seyfoddin A; Al-Kassas R
Drug Dev Ind Pharm; 2013 Apr; 39(4):508-19. PubMed ID: 22424312
[TBL] [Abstract][Full Text] [Related]
13. Quinapyramine sulfate-loaded sodium alginate nanoparticles show enhanced trypanocidal activity.
Manuja A; Kumar S; Dilbaghi N; Bhanjana G; Chopra M; Kaur H; Kumar R; Manuja BK; Singh SK; Yadav SC
Nanomedicine (Lond); 2014 Aug; 9(11):1625-34. PubMed ID: 24405513
[TBL] [Abstract][Full Text] [Related]
14. Albumin nanoparticles carrying cyclodextrins for nasal delivery of the anti-Alzheimer drug tacrine.
Luppi B; Bigucci F; Corace G; Delucca A; Cerchiara T; Sorrenti M; Catenacci L; Di Pietra AM; Zecchi V
Eur J Pharm Sci; 2011 Nov; 44(4):559-65. PubMed ID: 22009109
[TBL] [Abstract][Full Text] [Related]
15. Eudragit microparticles as a possible tool for ophthalmic administration of acyclovir.
Cortesi R; Ajanji SC; Sivieri E; Manservigi M; Fundueanu G; Menegatti E; Esposito E
J Microencapsul; 2007 Aug; 24(5):445-56. PubMed ID: 17578734
[TBL] [Abstract][Full Text] [Related]
16. Self-assembled drug delivery systems. 1. Properties and in vitro/in vivo behavior of acyclovir self-assembled nanoparticles (SAN).
Jin Y; Tong L; Ai P; Li M; Hou X
Int J Pharm; 2006 Feb; 309(1-2):199-207. PubMed ID: 16377106
[TBL] [Abstract][Full Text] [Related]
17. Nano and microparticulate chitosan-based systems for antiviral topical delivery.
Calderón L; Harris R; Cordoba-Diaz M; Elorza M; Elorza B; Lenoir J; Adriaens E; Remon JP; Heras A; Cordoba-Diaz D
Eur J Pharm Sci; 2013 Jan; 48(1-2):216-22. PubMed ID: 23159663
[TBL] [Abstract][Full Text] [Related]
18. Effect of inclusion complexation of meloxicam with β-cyclodextrin- and β-cyclodextrin-based nanosponges on solubility, in vitro release and stability studies.
Shende PK; Gaud RS; Bakal R; Patil D
Colloids Surf B Biointerfaces; 2015 Dec; 136():105-10. PubMed ID: 26364091
[TBL] [Abstract][Full Text] [Related]
19. Ethosomes for the delivery of anti-HSV-1 molecules: preparation, characterization and in vitro activity.
Cortesi R; Ravani L; Zaid AN; Menegatti E; Romagnoli R; Drechsler M; Esposito E
Pharmazie; 2010 Oct; 65(10):743-9. PubMed ID: 21105576
[TBL] [Abstract][Full Text] [Related]
20. In-vitro release of acyclovir loaded Eudragit RLPO(®) nanoparticles for sustained drug delivery.
Gandhi A; Jana S; Sen KK
Int J Biol Macromol; 2014 Jun; 67():478-82. PubMed ID: 24755259
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
